In recent years, much progress has been achieved in investigating the roles of BCL11A in some diseases, including β-hemoglobinopathies, hematological malignancies, malignant solid tumors, intellectual disability, and Type II diabetes (Figure 2 and Table 3). Here, BCL11A is linked to hematologic disorder.